Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Ovarian Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT00693342
What this trial is testing

Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete Remission

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Early research (Phase 1)Study completedNCT02217956
What this trial is testing

Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma

Who this might be right for
Ovarian AdenocarcinomaFallopian Tube AdenocarcinomaPrimary Peritoneal Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris 30
Early research (Phase 1)Study completedNCT00066456
What this trial is testing

Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CarcinomaPrimary Peritoneal CarcinomaRecurrent Ovarian Carcinoma+2 more
Gynecologic Oncology Group 13
Testing effectiveness (Phase 2)Study completedNCT00432094
What this trial is testing

Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors

Who this might be right for
Childhood Germ Cell TumorOvarian CancerTeratoma
Masonic Cancer Center, University of Minnesota 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT03428802
What this trial is testing

Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability

Who this might be right for
BRCA1 Gene MutationBRCA2 Gene MutationLocally Advanced Solid Neoplasm+17 more
Rutgers, The State University of New Jersey 21
Large-scale testing (Phase 3)Study completedNCT01015118
What this trial is testing

LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsPeritoneal Neoplasms
Boehringer Ingelheim 1,366
Early research (Phase 1)Study completedNCT00002913
What this trial is testing

Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer

Who this might be right for
Brenner TumorOvarian Clear Cell CystadenocarcinomaOvarian Endometrioid Adenocarcinoma+6 more
National Cancer Institute (NCI) 30
Not applicableUnknownNCT05749211
What this trial is testing

Huaier Granule in Combination With Nilaparil in Therapy Patients With Stage III/IV BRCA Wild-type Ovarian Cancer

Who this might be right for
Ovarian Cancer
Ruijin Hospital 59
Large-scale testing (Phase 3)Active Not RecruitingNCT03772028
What this trial is testing

Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Who this might be right for
Ovarian Cancer
The Netherlands Cancer Institute 538
Large-scale testing (Phase 3)Not Yet RecruitingNCT06539091
What this trial is testing

Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerEfficacySafety+2 more
Anhui Provincial Hospital 51
Large-scale testing (Phase 3)Not Yet RecruitingNCT07779538
What this trial is testing

Clinical Trials Comparing Trastuzumab Plus Bevacizumab With Bevacizumab as First-line Maintenance Therapy for Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 420
Testing effectiveness (Phase 2)Study completedNCT01010126
What this trial is testing

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaEndometrial Serous Adenocarcinoma+42 more
National Cancer Institute (NCI) 252
Testing effectiveness (Phase 2)Study completedNCT00004157
What this trial is testing

Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors

Who this might be right for
Breast CancerGestational Trophoblastic TumorKidney Cancer+5 more
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)UnknownNCT03371693
What this trial is testing

Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer

Who this might be right for
Ovarian CancerOvary NeoplasmOvarian Neoplasms+3 more
Zhongnan Hospital 112
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Very early researchWithdrawnNCT05238831
What this trial is testing

SMMART Adaptive Clinical Treatment (ACT) Trial

Who this might be right for
Advanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+14 more
OHSU Knight Cancer Institute
Large-scale testing (Phase 3)Study completedNCT01837251
What this trial is testing

Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer

Who this might be right for
Recurrent Platinum-sensitive Ovarian Cancer
AGO Research GmbH 682
Early research (Phase 1)Study completedNCT03784677
What this trial is testing

A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmRefractory Malignant Solid NeoplasmRefractory Ovarian Carcinoma+20 more
M.D. Anderson Cancer Center 11
Large-scale testing (Phase 3)Study completedNCT00003214
What this trial is testing

Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer

Who this might be right for
Ovarian Cancer
Swiss Cancer Institute 300
Next Page